alkaline phosphatase/neoplasms

FIELD OF THE INVENTION This invention relates to the use of human alkaline phosphatase, such as placental alkaline phosphatase or transferrin alone or alkaline phosphatase in combination with transferrin, and, optionally, .alpha..sub.1-antitrypsin to prevent or reduce the growth of skin cancer in

FIELD OF THE INVENTION Embodiments of this invention relate to the use of an alkaline phosphatase, such as placental alkaline phosphatase ("PALP"), to maintain muscle and adipose tissue mass in aging or diseased humans, who may or may not be treated with weight loss-inducing therapies. Alkaline

FIELD OF INVENTION Embodiments of this invention relate to the use of an alkaline phosphatase, such as placental alkaline phosphatase ("PALP"), to maintain muscle and adipose tissue mass in aging or diseased humans, who may or may not be treated with weight loss-inducing therapies. Alkaline

FIELD AND BACKGROUND OF THE INVENTION The present invention relates to a method of detecting cancer and, more particularly, to methods of optimizing drug treatment for cancer. Cancer is responsible for the majority of morbidity and mortality worldwide, despite recent advances in medical technology.

SEQUENCE LISTING The present disclosure includes a sequence listing incorporated herein by reference in its entirety. FIELD OF THE DISCLOSURE The present disclosure relates to recombinant nucleic acid minicircles useful for the tumor-specific expression of heterologous coding nucleic acid sequences

FIELD OF THE INVENTION This invention relates generally to novel compounds useful as inhibitors of alkaline phosphatase. These compounds are useful in immunoassays. They can be used as cancer therapeutics; antihelmintics; anti-depressive/psychoenergising, antianergic, and anti-anorexigenic

TECHNICAL FIELD OF THE INVENTION The present invention relates to a novel method for the delivery of cytotoxic agents to tumor cells by the combined use of antibody-enzyme conjugates and prodrugs. More particularly, this invention relates to a method for the delivery of cytotoxic drugs to the site

FIELD OF INVENTION The present invention relates to cell specific therapeutic modality by using a region of the PLAP Promoter. The invention further relates to specific expression of therapeutically useful sequences for specific transcriptional activation under PLAP promoter. The invention also

FIELD OF THE INVENTION The invention relates generally to compounds for the treatment of medical conditions involving hormones. More specifically, the invention relates to compounds, their preparation and their use in the treatment of hormone-dependent diseases including hormone-dependent cancers. A

FIELD OF THE PRESENT INVENTION The present invention relates to a previously unknown human receptor protein, H4-1BB, which was isolated and identified based upon work with a homologous murine (mouse) receptor protein, 4-1BB, which was isolated and identified by specific expression of the T cell

The subject matter described herein was in part a subject invention of NIH Grants Nos. IR23AI23058-03, R01 AI-28175, R01 DE-12156, and P60 KD20542 of which the present inventor was the Principal Investigator and either the Donald Guthrie Foundation for Medical Research Inc. of Guthrie Square, Sayre,

FIELD OF THE PRESENT INVENTION The present invention relates to the therapeutic and scientific uses for the human H4-1BB protein, its ligands, and the development of monoclonal antibodies that recognize and bind the H4-1BB receptor protein. BACKGROUND OF THE PRESENT INVENTION The immune system of

The present invention relates to the use of carprofen in mammals as a means of treating and preventing cartilage and subchondral bone injury and loss in the inflamed joints of such mammals. Such damage to the cartilage and subchondral bone is a natural sequelae of the process of osteoarthritis and

FIELD OF THE INVENTION The present invention relates to the use of purified limonoin glucoside for the treatment of chronic inflammatory diseases. BACKGROUND OF THE INVENTION Circulating concentrations of the hepatic enzymes gamma glutamyl transferase (GGT), alanine amino transferase (ALT), alkaline

FIELD OF THE INVENTION The present invention relates generally to immunological testing methods, and more particularly to such methods for detection of antibodies against a chorionic gonadotropin-like substance. SUMMARY OF THE INVENTION The present invention comprises a method of detecting the